文献速递前列腺癌

预测前列腺癌根治术后侧别特异性包膜外侵犯的新型列线图开发与外部验证

Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy.
PubMed 文献 · Eur Urol Oncol · 2020-09-22

基于三个中心1870例机器人辅助根治性前列腺切除术患者的回顾性数据,开发并外部验证了包含mpMRI信息的列线图预测侧别特异性包膜外侵犯。外部验证中四个模型AUC范围0.77-0.83,含mpMRI分期的模型AUC相对较高,基于PSA密度、ISUP分级和mpMRI T分期的模型校准更优。使用20%截断值时,68%无EPE腺叶可考虑保留神经,77%有EPE腺叶建议不保留神经。

要点

  • 含mpMRI分期的列线图外部验证AUC达0.77-0.83,优于不含mpMRI模型
  • 基于PSA密度、ISUP分级和mpMRI T分期的模型校准最佳
  • 20%截断值下68%无EPE腺叶可保留神经,77%有EPE腺叶建议不保留

核心结论

  • 开发了简单稳健的列线图预测侧别特异性EPE,可用于选择保留神经的RP患者。

研究设计与样本

  • 回顾性分析2014-2018年三个中心1870例连续接受机器人辅助RP的前列腺癌患者。
  • 建立四个多变量逻辑回归模型,组合患者水平和侧别特异性变量。
  • 在开发队列和两个外部验证队列中评估区分度、校准和净获益。

主要发现

  • 外部验证中四个模型AUC在队列1为0.80(95%CI 0.68-0.88)至0.83(95%CI 0.72-0.90)。
  • 外部验证中四个模型AUC在队列2为0.77(95%CI 0.62-0.87)至0.78(95%CI 0.64-0.88)。
  • 含mpMRI分期信息的三个模型AUC相对高于不含mpMRI信息的模型。
  • 四个模型间净获益无重大差异。
  • 基于PSA密度、ISUP分级和mpMRI T分期的模型校准更优。

关键数值与推荐

  • 使用基于PSA密度、ISUP分级和mpMRI T分期的模型,截断值20%时,1980/2908(68%)无EPE前列腺叶符合保留神经条件。
  • 同一模型截断值20%时,642/832(77%)有EPE前列腺叶建议不保留神经。

临床怎么用

  • 列线图可用于术前评估侧别特异性EPE风险,指导保留神经RP的患者选择。

局限性

  • 回顾性分析设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prediction of side-specific extraprostatic extension (EPE) is crucial in selecting patients for nerve-sparing radical prostatectomy (RP). OBJECTIVE: To develop and externally validate nomograms including multiparametric magnetic resonance imaging (mpMRI) information to predict side-specific EPE. DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis of 1870 consecutive prostate cancer patients who underwent robot-assisted RP from 2014 to 2018 at three institutions. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Four multivariable logistic regression models were established, including combinations of patient-based and side-specific variables: prostate-specific antigen (PSA) density, highest ipsilateral International Society of Urological Pathology (ISUP) biopsy grade, ipsilateral percentage of positive cores on systematic biopsy, and side-specific clinical stage assessed by both digital rectal examination and mpMRI. Discrimination (area under the curve [AUC]), calibration, and net benefit of these models were assessed in the development cohort and two external validation cohorts. RESULTS AND LIMITATIONS: On external validation, AUCs of the four models ranged from 0.80 (95% confidence interval [CI] 0.68-0.88) to 0.83 (95% CI 0.72-0.90) in cohort 1 and from 0.77 (95% CI 0.62-0.87) to 0.78 (95% CI 0.64-0.88) in cohort 2. The three models including mpMRI staging information resulted in relatively higher AUCs compared with the model without mpMRI information. No major differences between the four models regarding net benefit were established. The model based on PSA density, ISUP grade, and mpMRI T stage was superior in terms of calibration. Using this model with a cut-off of 20%, 1980/2908 (68%) prostatic lobes without EPE would be found eligible for nerve sparing, whereas non-nerve sparing would be advised in 642/832 (77%) lobes with EPE. CONCLUSIONS: Our analysis resulted in a simple and robust nomogram for the prediction of side-specific EPE, which should be used to select patients for nerve-sparing RP. PATIENT SUMMARY: We developed a prediction model that can be used to assess accurately the likelihood of tumour extension outside the prostate. This tool can guide patient selection for safe nerve-sparing surgery.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Soeterik TFW, van Melick HHE, Dijksman LM, et al. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Eur Urol Oncol. 2020. PMID: 32972895. doi:10.1016/j.euo.2020.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。